A month after going on medical leave, the president and chief executive resigned from Davis biotech firm Arcadia Biosciences Inc.
The company announced the departure of Eric Rey, the co-founder of Arcadia, who went on leave in mid-January to have a stent installed in a coronary artery. At the time, Arcadia said the leave would be short term and Rey was expected to make a full recovery.
Arcadia named Roger Salameh, vice president of business development, as interim CEO while a search gets underway for Rey’s replacement.
The company develops farm biotech products, including products to make crops more salt tolerant and less thirsty.
Arcadia shares closed at $2.32, down 8 cents, on the Nasdaq market. Rey’s resignation was announced after the market closed.